These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

96 related articles for article (PubMed ID: 27463490)

  • 1. CLL Trials in the United Kingdom the Medical Research Council CLL Trials 1, 2 and 3.
    Catovsky D; Richards S; Fooks J; Hamblin TJ
    Leuk Lymphoma; 1991; 5 Suppl 1():105-11. PubMed ID: 27463490
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The UK Medical Research Council CLL trials 1 and 2.
    Catovsky D; Fooks J; Richards S
    Nouv Rev Fr Hematol (1978); 1988; 30(5-6):423-7. PubMed ID: 3222154
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Therapeutic Results from the Trials Managed by the French Cooperative Group on Chronic Lymphocytic Leukemia.
    French Cooperative Group On Chronic Lymphocytic Leukemia
    Leuk Lymphoma; 1991; 5 Suppl 1():83-8. PubMed ID: 27463485
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Chlorambucil plus theophylline vs chlorambucil alone as a front line therapy for B-cell chronic lymphatic leukemia.
    Mabed M; Aref S; Fouda M; El-Sharawy S
    Leuk Lymphoma; 2004 Oct; 45(10):2029-35. PubMed ID: 15370247
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Chlorambucil in indolent chronic lymphocytic leukemia. French Cooperative Group on Chronic Lymphocytic Leukemia.
    Dighiero G; Maloum K; Desablens B; Cazin B; Navarro M; Leblay R; Leporrier M; Jaubert J; Lepeu G; Dreyfus B; Binet JL; Travade P
    N Engl J Med; 1998 May; 338(21):1506-14. PubMed ID: 9593789
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Oblimersen: Augmerosen, BCL-2 antisense oligonucleotide - Genta, G 3139, GC 3139, oblimersen sodium.
    Drugs R D; 2007; 8(5):321-34. PubMed ID: 17767397
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prolonged Intermittent Chlorambucil Administration in B-Chronic Lymphocytic Leukemia: Experience from a Single Hematology Unit.
    Boussiotis VA; Panayiotidis PG; Pangalis GA
    Leuk Lymphoma; 1991; 5 Suppl 1():113-7. PubMed ID: 27463491
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pentostatin (Nipent) and chlorambucil with granulocyte-macrophage colony-stimulating factor support for patients with previously untreated, treated, and fludarabine-refractory B-cell chronic lymphocytic leukemia.
    Waselenko JK; Grever MR; Beer M; Lucas MA; Byrd JC
    Semin Oncol; 2000 Apr; 27(2 Suppl 5):44-51. PubMed ID: 10877052
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Treatment of Chronic Lymphocytic Leukemia: A Preliminary Report of Spanish (Pethema) Trials.
    Spanish Cooperative Group Pethema
    Leuk Lymphoma; 1991; 5 Suppl 1():89-91. PubMed ID: 27463486
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The experience of the French Cooperative Group in the treatment of CLL.
    Travade P
    Nouv Rev Fr Hematol (1978); 1990; 32(5):313-7. PubMed ID: 2099402
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Management of chronic lymphocytic leukemia.
    Han T; Rai KR
    Hematol Oncol Clin North Am; 1990 Apr; 4(2):431-45. PubMed ID: 2182600
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Rituximab for the first-line treatment of stage III-IV follicular lymphoma (review of Technology Appraisal No. 110): a systematic review and economic evaluation.
    Papaioannou D; Rafia R; Rathbone J; Stevenson M; Buckley Woods H; Stevens J
    Health Technol Assess; 2012; 16(37):1-253, iii-iv. PubMed ID: 23021127
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Treatment of indolent B-Cell nonfollicular lymphomas: final results of the LL01 randomized trial of the Gruppo Italiano per lo Studio dei Linfomi.
    Baldini L; Brugiatelli M; Luminari S; Lombardo M; Merli F; Sacchi S; Gobbi P; Liberati M; Cavanna L; Colombi M; Stelitano C; Goldaniga M; Morabito F; Federico M; Silingardi V;
    J Clin Oncol; 2003 Apr; 21(8):1459-65. PubMed ID: 12697867
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Treatment approach for elderly and unfit patients with chronic lymphocytic leukemia.
    Innocenti I; Autore F; Pasquale R; Morelli F; Efremov DG; Laurenti L
    Expert Rev Hematol; 2017 Dec; 10(12):1069-1076. PubMed ID: 29082795
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Combination of Cytosine-Arabinoside (ARA-C), Cyclophosphamide and Prednisone in the Treatment of B-Chronic Lymphocytic Leukemia in Advanced Stages and Progressive Disease.
    Rossi GD; Mauro FR; Pizzo F; Coluzzi S; Luciani M; Mandelli F
    Leuk Lymphoma; 1991; 5 Suppl 1():101-3. PubMed ID: 27463489
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The clinical effectiveness and cost-effectiveness of rituximab for the first-line treatment of chronic lymphocytic leukaemia: an evidence review of the submission from Roche.
    Main C; Pitt M; Moxham T; Stein K
    Health Technol Assess; 2010 Oct; 14(Suppl. 2):27-32. PubMed ID: 21047488
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The place of cladribine in the treatment of chronic lymphocytic leukemia: a 10-year experience in Poland.
    Robak T
    Ann Hematol; 2005 Feb; 84(2):63-70. PubMed ID: 15558283
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Management of chronic lymphocytic leukaemia.
    Kalil N; Cheson BD
    Drugs Aging; 2000 Jan; 16(1):9-27. PubMed ID: 10733261
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A randomized trial comparing chlorambucil plus prednisone vs cyclophosphamide, melphalan, and prednisone in the treatment of chronic lymphocytic leukemia stages B and C.
    Montserrat E; Alcalá A; Alonso C; Besalduch J; Moraleda JM; García-Conde J; Gutierrez M; Gomis F; Garijo J; Guzmán MC
    Nouv Rev Fr Hematol (1978); 1988; 30(5-6):429-32. PubMed ID: 3065738
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Does intensive treatment with high dose chlorambucil and prednisone as first line and cladribine as second line influence the survival of the patients with chronic lymphocytic leukemia?
    Robak T; Błoński JZ; Kasznicki M
    Leuk Lymphoma; 2001 May; 41(5-6):545-57. PubMed ID: 11378572
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.